Recent studies suggest a noteworthy correlation between IDH genotypes of gliomas and the phenotypic diversity of GAMs in the pertinent TME,[15] implying a potential role of IDH mutations in the interplay between gliomas and their associated GAMs. This evidence concerns the gene IDH1 and central nervous system cancer.